{
    "2021-07-19": [
        [
            {
                "time": "",
                "original_text": "上半年营收净利润双降，市值跌去4成，华大基因还有多少泡沫？ 盈利能力下降",
                "features": {
                    "keywords": [
                        "华大基因",
                        "营收",
                        "净利润",
                        "市值",
                        "盈利能力",
                        "下降"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "26家医疗器械上市公司业绩预增 疫情是影响主因",
                "features": {
                    "keywords": [
                        "医疗器械",
                        "上市公司",
                        "业绩预增",
                        "疫情"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械",
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}